Saia to Announce Fourth Quarter 2020 Results on February 8, 2021

JOHNS CREEK, Ga., Jan. 11, 2021 (GLOBE NEWSWIRE) — Saia, Inc. (NASDAQ: SAIA), a leading transportation provider offering multi-regional less-than-truckload (LTL), non-asset truckload, expedited and logistics services, announced that it will release its quarterly financial results before the market opens on Monday, February 8. Saia management will host a conference call to discuss the results later that morning at 10:00 a.m. Eastern Time.

To participate in the call, please dial 800-437-2398 or 323-289-6576 referencing conference ID #1022163. Callers should dial in five to ten minutes in advance of the conference call. This call will be webcast live via the company website at https://www.saia.com/about-us/investor-relations/financial-releases. A replay of the call will be offered two hours after the completion of the call through March 8 at 1:00 p.m. Eastern Time. The replay will be available by dialing 888-203-1112.

Saia, Inc. (NASDAQ: SAIA) offers customers a wide range of less-than-truckload, non-asset truckload, expedited and logistics services. With headquarters in Georgia, Saia LTL Freight operates 169 terminals in 44 states. For more information on Saia, Inc. visit the Investor Relations section at https://www.saia.com/about-us/investor-relations

 

CONTACT: Saia, Inc.
  Melanie Baker
  770.232.4088
  [email protected] 

 



Equity Commonwealth Declares Series D Preferred Dividend

Equity Commonwealth Declares Series D Preferred Dividend

CHICAGO–(BUSINESS WIRE)–
Equity Commonwealth (NYSE: EQC) announced today that its Board of Trustees declared a dividend on the company’s Series D Preferred Shares. A quarterly dividend of $0.40625 per Series D Preferred Share will be paid on February 16, 2021 to shareholders of record on January 28, 2021 for the period from November 15, 2020 through February 14, 2021.

About Equity Commonwealth

Equity Commonwealth (NYSE: EQC) is a Chicago based, internally managed and self-advised real estate investment trust (REIT) with commercial office properties in the United States. EQC’s same property portfolio is comprised of 4 properties and 1.5 million square feet.

Regulation FD Disclosures

We intend to use any of the following to comply with our disclosure obligations under Regulation FD: press releases, SEC filings, public conference calls, or our website. We routinely post important information on our website at www.eqcre.com, including information that may be deemed to be material. We encourage investors and others interested in the company to monitor these distribution channels for material disclosures.

Forward-Looking Statements

This press release may contain forward-looking statements and information within the meaning of the federal securities laws. These statements are based on current expectations, estimates, projections and assumptions made by management. While Equity Commonwealth management believes the assumptions underlying its forward-looking statements are reasonable, such information is inherently subject to uncertainties and may involve certain risks. Other risks and uncertainties are described under the heading “Risk Factors” in our Annual Report on Form 10-K and subsequent periodic reports filed with the Securities and Exchange Commission (SEC) and available on our website, www.eqcre.com. Many of these uncertainties and risks are difficult to predict and beyond management’s control. Forward-looking statements are not guarantees of future performance, results or events. Equity Commonwealth assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events.

Investor Contact

Sarah Byrnes, Equity Commonwealth, (312) 646-2801

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Residential Building & Real Estate Commercial Building & Real Estate Construction & Property REIT

MEDIA:

Logo
Logo

VectoIQ Acquisition Corp. II Closes $345 Million Initial Public Offering

PR Newswire

NEW YORK, Jan. 11, 2021 /PRNewswire/ — VectoIQ Acquisition Corp. II (the “Company”) today announced that it closed its initial public offering of 34,500,000 units, which included the full exercise of the underwriters’ over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $345,000,000, before deducting underwriting discounts and commissions and other offering expense payable by the Company.

The Company’s units began trading on the Nasdaq Capital Market (“Nasdaq”) under the ticker symbol “VTIQU” on January 7, 2021. Each unit consists of one share of the Company’s common stock and one-fifth of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of common stock at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Company expects that its common stock and warrants will be listed on Nasdaq under the symbols ”VTIQ” and ”VTIQW,” respectively.

The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company’s efforts to identify a prospective target business will not be limited to a particular industry or geographic region, although it intends to focus on businesses in the industrial technology, transportation and smart mobility industries. The proceeds of the offering will be used to fund such a business combination.

Cowen and Company, LLC and Morgan Stanley & Co. LLC acted as the joint book-running managers.

The public offering was made by means of a prospectus. Copies of the prospectus relating to the offering may be obtained from Cowen and Company, LLC, c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, NY 11717, Attn: Prospectus Department, email: [email protected], telephone: 833-297-2926; or Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, NY 10014, Attn: Prospectus Department, email: [email protected]. 

A registration statement relating to the securities has been filed with the U.S. Securities and Exchange Commission (the “SEC”) and became effective on January 6, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About VectoIQ Acquisition Corp. II

VectoIQ Acquisition Corp. II, a Delaware corporation, is a blank check company newly formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company’s management team is led by Stephen Girsky, Chief Executive Officer and Director.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the anticipated use of the net proceeds of the initial public offering. No assurance can be given that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and preliminary prospectus for the offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contacts:

Gladstone Place Partners
Lauren Odell / Danielle Belopotosky
212-230-5930

Cision View original content:http://www.prnewswire.com/news-releases/vectoiq-acquisition-corp-ii-closes-345-million-initial-public-offering-301205644.html

SOURCE VectoIQ Acquisition Corp. II

Otis Recommends Shareholders Reject TRC Capital “Mini-Tender” Offer

– Unsolicited mini-tender offer is below current market price for Otis shares

– Shareholders who have already tendered shares advised to withdraw

– Otis urges investors to review current share price, exercise caution and consult with advisors

PR Newswire

FARMINGTON, Conn., Jan. 11, 2021 /PRNewswire/ — Otis Worldwide Corporation (NYSE: OTIS) received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation (“TRC Capital”) to purchase up to 2 million shares, or about 0.46 percent, of Otis’s outstanding common stock at a price of $62.75 per share in cash. As TRC Capital’s own offer document acknowledges, the offering price is approximately 4.62 percentbelow the closing price per share of Otis on Dec. 24, 2020, the last trading day before the mini-tender offer was commenced. Otis recommends that shareholders reject this unsolicited offer because the offer price is below the current market price for Otis shares. The offer also is subject to numerous conditions, including TRC Capital obtaining sufficient financing necessary to consummate the offer. Otis also recommends that any shareholders who have tendered shares to TRC Capital withdraw those shares by providing the written notice described in the offering documentation before the expiration of the offer, which is currently scheduled for 12:01 a.m., New York City Time, on Jan. 27, 2021.

Otis is not associated with TRC Capital, its mini-tender offer or the mini-tender offer documentation.

TRC Capital has made similar unsolicited mini-tender offers for shares of other public companies. Mini-tender offers are designed to seek less than 5 percent of a company’s outstanding shares, thereby avoiding many investor protections, including the disclosure and procedural requirements, applicable to larger tender offers under United States securities laws. The U.S. Securities and Exchange Commission (SEC) has cautioned investors about mini-tender offers, noting that “some bidders make mini-tender offers at below-market prices, hoping that they will catch investors off guard if the investors do not compare the offer price to the current market price.” The SEC has also published investor tips regarding these offers on its website at: http://www.sec.gov/investor/pubs/minitend.htm.

Otis encourages brokers and dealers, as well as other market participants, to review the SEC’s letter regarding broker-dealer mini-tender offer dissemination and disclosures on the SEC’s website at:  http://www.sec.gov/divisions/marketreg/minitenders/sia072401.htm.

Otis urges investors to obtain current market quotations for their shares, consult with their brokers or financial advisors and exercise caution with respect to TRC Capital’s offer.

Otis requests that a copy of this news release be included with all distributions of materials relating to TRC Capital’s mini-tender offer related to Otis’s shares of common stock.

About Otis

Otis is the world’s leading elevator and escalator manufacturing, installation and service company. We move 2 billion people a day and maintain more than 2 million customer units worldwide, the industry’s largest Service portfolio. Headquartered in Connecticut, USA, Otis is 69,000 people strong, including 40,000 field professionals, all committed to meeting the diverse needs of our customers and passengers in more than 200 countries and territories worldwide. For more information, visit www.otis.com and follow us on LinkedIn, Instagram, Facebook and Twitter @OtisElevatorCo.


Media
Contact:

Ray Hernandez

+1-860-674-3029


[email protected]


IR Contact:

Stacy Laszewski

+1-860-676-6011


[email protected]

 

Cision View original content:http://www.prnewswire.com/news-releases/otis-recommends-shareholders-reject-trc-capital-mini-tender-offer-301205578.html

SOURCE Otis Worldwide Corporation

IAC Monthly Metrics Available on Company’s IR Site

PR Newswire

NEW YORK, Jan. 11, 2021 /PRNewswire/ — IAC (NASDAQ: IAC) posted monthly metrics for December 2020 on the investor relations section of its website at https://ir.iac.com/.

About IAC
IAC builds companies.  We are guided by curiosity, a questioning of the status quo, and a desire to invent or acquire new products and brands.  From the single seed that started as IAC over two decades ago have emerged 10 public companies and generations of exceptional leaders.  We will always evolve, but our basic principles of financially-disciplined opportunism will never change.  IAC today operates Vimeo, Dotdash and Care.com, among many others, and has majority ownership of ANGI Homeservices, which includes HomeAdvisor, Angie’s List and Handy.  The Company is headquartered in New York City and has business operations and satellite offices worldwide.

Cision View original content:http://www.prnewswire.com/news-releases/iac-monthly-metrics-available-on-companys-ir-site-301205582.html

SOURCE IAC

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

Lille, France; Cambridge, MA; January 11, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, today announced the half-year report of the liquidity contract with Crédit Industriel et Commercial.

Under the liquidity contract GENFIT has with Crédit Industriel et Commercial, the following resources appeared on the liquidity account as of December 31, 2020:

  • 88,929 shares
  • €687 988.75

During the second half of 2020, total trading was:

  • On the buy side: 1,525,427 shares for a total amount of €6,221,316.16
  • On the sell side: 1,484,196 shares for a total amount of €6,066,211.46

During this same period, the number of trades were:

  • On the buy side: 2,623
  • On the sell side: 2,638

As a reminder, upon signing of the contract, the following resources appeared on the liquidity account:

  • 27, 911 shares
  • €769 849,43

ABOUT GENFIT

GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with cholestatic and metabolic chronic liver diseases. GENFIT is a pioneer in the field of nuclear receptor-based drug discovery, with a rich history and strong scientific heritage spanning more than two decades. GENFIT is currently enrolling in ELATIVE™, a Phase 3 clinical trial evaluating elafibranor in patients with Primary Biliary Cholangitis (PBC). As part of GENFIT’s comprehensive approach to clinical management of patients with liver disease, the Company is also developing NIS4™, a new, non-invasive blood-based diagnostic technology which could enable easier identification of patients with at-risk NASH.  NIS4™ technology has been licensed to LabCorp in the U.S. and Canada for the development and commercialization of a blood-based molecular diagnostic test powered by NIS4™ technology. GENFIT has facilities in Lille and Paris, France, and Cambridge, MA, USA. GENFIT is a publicly traded company listed on the Nasdaq Global Select Market and on compartment B of Euronext’s regulated market in Paris (Nasdaq and Euronext: GNFT). www.genfit.com

FORWARD LOOKING STATEMENTS

This press release contains certain forward-looking statements with respect to GENFIT, including those within the meaning of the Private Securities Litigation Reform Act of 1995, with respect to GENFIT, including statements regarding the objective of its research and development programs. The use of certain words, including “consider”, “contemplate”, “think”, “aim”, “expect”, “understand”, “should”, “aspire”, “estimate”, “believe”, “wish”, “may”, “could”, “allow”, “seek”, “encourage” or “have confidence” or (as the case may be) the negative forms of such terms or any other variant of such terms or other terms similar to them in meaning is intended to identify forward-looking statements. Although the Company believes its projections are based on reasonable expectations and assumptions of the Company’s management, these forward-looking statements are subject to numerous known and unknown risks and uncertainties, which could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including in relation to safety, biomarkers, progression of, and results from, its ongoing and planned clinical trials, review and approvals by regulatory authorities of its drug and diagnostic candidates, exchange rate fluctuations and the Company’s continued ability to raise capital to fund its development, as well as those risks and uncertainties discussed or identified in the Company’s public filings with the AMF, including those listed in Chapter 2 “Main Risks and Uncertainties” of the Company’s 2019 Universal Registration Document filed with the AMF on 27 May 2020 under n° D.20-0503 and in Section 2 “Risk Factors” of the Company’s Amendment to the Universal Registration Document filed with the AMF on 22 December 2020 under n° D.20-0503-A01, which are available on the Company’s website (www.genfit.com) and on the website of the AMF (www.amf-france.org) and public filings and reports filed with the U.S. Securities and Exchange Commission (“SEC”) including the Company’s 2019 Annual Report on Form 20-F filed with the SEC on May 27, 2020. In addition, even if the Company’s results, performance, financial condition and liquidity, and the development of the industry in which it operates are consistent with such forward-looking statements, they may not be predictive of results or developments in future periods.  These forward-looking statements speak only as of the date of publication of this document. Other than as required by applicable law, the Company does not undertake any obligation to update or revise any forward-looking information or statements, whether as a result of new information, future events or otherwise.

CONTACT

GENFIT | Investors

Naomi EICHENBAUM – Investor Relations | Tel: +1 (617) 714 5252 | [email protected]

PRESS RELATIONS | Media

Hélène LAVIN – Press relations | Tel: +333 2016 4000 | [email protected]

GENFIT | 885 Avenue Eugène Avinée, 59120 Loos – FRANCE | +333 2016 4000 | www.genfit.com       

APPENDIX
H2 2020

  Buy Side Sell Side
Date Number of executions Number of shares Traded amounts in EUR Number of executions Number of shares Traded amount in EUR
TOTAL 2 623 1 525 427 6 221 316,16 2 638 1 484 196 6 066 211,46
01/07/2020 8 5001 24 555,04 2 1001 4 905,04
02/07/2020 10 6001 29 254,86 9 6001 29 554,86
03/07/2020 4 3001 14 554,89 5 3001 14 704,89
06/07/2020 8 5001 24 094,90 8 4001 19 454,90
07/07/2020 10 3001 14 354,90 8 4001 19 404,90
08/07/2020 2 1001 4 854,91 5 3001 14 854,91
09/07/2020 14 6001 28 804,92 5 2001 9 604,92
10/07/2020 5 3001 14 104,72 5 3001 14 254,72
13/07/2020 9 4001 18 704,73 4 1001 4 804,73
14/07/2020 12 7001 31 772,69 1 1 4,69
15/07/2020 2 1001 4 504,54 12 6001 27 804,54
16/07/2020 6 3001 13 804,64 6 2001 9 304,64
17/07/2020 3 2001 9 054,60 4 3001 13 804,60
20/07/2020 8 4001 19 304,62 19 10001 48 454,62
21/07/2020 6 3001 15 004,97 6 3001 15 154,97
22/07/2020 9 5001 23 804,93 1 1 4,93
23/07/2020 35 14001 65 957,73 30 18001 85 604,61
24/07/2020 6 5001 23 304,75 7 3001 14 004,75
27/07/2020 6 3001 13 804,70 3 1001 4 604,70
28/07/2020 9 4001 18 054,56 2 1001 4 554,56
29/07/2020 16 8001 34 390,48 6 2001 8 554,48
30/07/2020 12 7001 28 104,18 5 2001 7 954,18
31/07/2020 9 4001 16 853,98 18 9052 37 771,24
03/08/2020 4 1241 5 138,18 8 3241 13 751,14
04/08/2020 7 4001 17 104,34 9 2001 8 754,34
05/08/2020 30 13001 59 404,45 30 18001 82 412,45
06/08/2020 8 4001 17 554,40 7 3001 13 354,40
07/08/2020 6 4001 16 904,36 8 2001 8 454,36
10/08/2020 5 2001 8 454,24 2 1001 4 304,24
11/08/2020 7 5001 22 364,24 19 10001 44 504,24
12/08/2020 11 5001 21 954,38 7 4001 17 754,38
13/08/2020 9 3001 13 154,40 16 5001 22 204,40
14/08/2020 8 4001 17 504,46 1 1 4,46
17/08/2020 4 4001 17 904,38 11 6001 26 764,38
18/08/2020 14 10001 44 504,41 9 8001 36 104,41
19/08/2020 7 4001 17 704,44 9 6001 26 804,44
20/08/2020 6 4001 17 604,49 6 2001 8 904,49
21/08/2020 7 6001 26 704,41 10 8001 35 904,41
24/08/2020 13 6001 26 404,50 5 2001 9 004,50
25/08/2020 8 3001 13 004,39 3 1578 6 943,19
26/08/2020 6 2001 8 604,30 2 1001 4 354,30
27/08/2020 9 3001 12 694,36 2 1001 4 254,32
28/08/2020 17 2001 8 504,26 3 2001 8 604,26
31/08/2020 2 2001 8 504,29 3 2001 8 604,29
01/09/2020 6 3001 12 654,23 3 2001 8 604,23
02/09/2020 4 2001 8 304,18 3 1001 4 204,18
03/09/2020 9 4001 16 304,16 1 1 4,16
04/09/2020 5 2001 8 104,02 5 4001 16 404,02
07/09/2020 1 1 4,08 4 2001 8 304,08
08/09/2020 4 4001 16 304,15 1 1 4,15
09/09/2020 1 1 4,03 1 1 4,03
10/09/2020 9 4001 16 004,00 9 4001 16 204,00
11/09/2020 3 2038 8 335,39 10 4038 16 576,13
14/09/2020 6 5570 22 810,71 7 3533 14 570,02
15/09/2020 10 6001 24 564,16 12 10038 41 461,93
16/09/2020 14 12355 50 000,76 10 6759 27 377,22
17/09/2020 6 4338 17 401,90 5 3092 12 478,54
18/09/2020 15 13764 53 711,81 3 1785 7 122,15
21/09/2020 54 35711 130 617,19 23 23214 85 930,14
22/09/2020 56 37780 128 579,53 37 23425 79 505,48
23/09/2020 10 11053 37 777,14 37 21858 75 243,80
24/09/2020 42 26518 84 804,49 15 10566 33 938,12
25/09/2020 3 1001 3 303,22 71 40193 138 949,64
28/09/2020 42 28001 122 194,04 94 65580 280 622,39
29/09/2020 108 59184 289 427,62 81 44688 222 574,69
30/09/2020 77 46079 223 282,94 69 56966 276 415,17
01/10/2020 156 105679 445 527,89 108 65077 272 012,83
02/10/2020 64 30822 118 216,54 52 33382 129 847,68
05/10/2020 9 3697 14 719,50 11 4222 16 967,97
06/10/2020 1 1 3,98 1 1 3,98
07/10/2020 1 1 3,99 1 1 3,99
08/10/2020 12 6544 25 408,57 7 5158 20 154,63
09/10/2020 10 4761 18 497,21 3 1739 6 821,87
12/10/2020 39 20648 77 097,64 9 7489 27 937,17
13/10/2020 32 20443 72 373,38 18 16209 57 406,80
14/10/2020 12 5294 19 231,27 19 8435 30 823,04
15/10/2020 21 18208 68 856,25 54 30596 116 103,18
16/10/2020 6 5039 19 009,89 3 1279 4 844,91
19/10/2020 1 1 3,75 1 1 3,75
20/10/2020 13 6035 21 826,87 5 3018 11 005,80
21/10/2020 4 1692 5 999,90 4 4018 14 565,70
22/10/2020 16 5188 18 205,33 9 4605 16 316,83
23/10/2020 1 1190 4 176,90 3 2603 9 465,86
26/10/2020 24 13605 46 421,81 1 1 3,50
27/10/2020 42 32038 103 966,86 35 24282 78 944,36
28/10/2020 72 41189 128 615,54 43 44311 140 078,49
29/10/2020 20 11619 36 288,07 7 3454 10 852,04
30/10/2020 20 11623 36 080,25 26 17594 55 071,51
02/11/2020 47 31878 107 111,05 70 41096 137 798,09
03/11/2020 25 20530 69 640,13 36 19350 66 143,53
04/11/2020 27 19404 67 560,68 59 34582 120 337,38
05/11/2020 17 11841 41 744,28 46 19134 68 071,56
06/11/2020 35 19675 67 566,81 19 7002 24 253,56
09/11/2020 35 23518 80 982,51 45 28155 98 055,10
10/11/2020 25 19780 70 120,34 56 25327 89 877,35
11/11/2020 161 82363 354 327,31 245 109412 459 433,58
12/11/2020 56 35001 154 864,28 72 35001 155 314,28
13/11/2020 40 20101 83 015,18 32 18101 75 067,18
16/11/2020 59 30000 122 390,00 57 23863 98 453,67
17/11/2020 22 12001 47 694,11 37 12888 51 705,68
18/11/2020 9 4000 16 299,40 5 4000 16 444,00
19/11/2020 1 1 4,12 1 1 4,12
20/11/2020 4 2001 8 344,12 6 2251 9 401,62
23/11/2020 16 10001 41 074,19 17 9001 37 234,19
24/11/2020 30 13002 54 678,41 35 20001 84 534,13
25/11/2020 32 19000 80 960,12 30 18001 77 242,40
26/11/2020 17 11126 48 980,52 44 19001 84 004,27
27/11/2020 72 35001 172 560,61 71 37001 182 874,70
30/11/2020 44 26876 128 527,54 47 20008 98 479,34
01/12/2020 12 7001 31 714,47 11 7085 32 400,87
02/12/2020 14 8001 35 274,60 16 6002 26 520,70
03/12/2020 29 8953 39 698,47 16 8953 39 913,51
04/12/2020 9 4400 19 754,07 9 4896 22 143,93
07/12/2020 21 10602 47 624,48 21 11702 52 956,30
08/12/2020 28 13299 60 325,22 24 15562 71 181,83
09/12/2020 5 4001 18 496,70 6 4001 18 654,70
10/12/2020 12 6564 29 713,04 8 4601 20 852,65
11/12/2020 94 59167 247 064,47 72 40609 168 101,98
14/12/2020 48 31450 128 194,41 35 26439 108 050,57
15/12/2020 18 11746 47 469,01 19 9827 39 863,39
16/12/2020 18 11191 44 847,24 10 5532 22 431,84
17/12/2020 15 8629 34 338,71 22 18281 73 728,55
18/12/2020 8 5343 21 826,94 4 2672 10 968,95
21/12/2020 14 7007 27 755,33 2 2001 8 064,00
22/12/2020 6 4122 16 825,67 10 5122 20 939,24
23/12/2020 11 6928 27 938,15 7 6928 28 076,69
24/12/2020 9 6106 25 213,23 12 6162 25 604,31
28/12/2020 9 6465 25 871,03 9 5001 20 218,05
29/12/2020 8 4348 17 227,18 16 3869 15 467,69
30/12/2020 1 1 3,96 13 3589 14 473,60
31/12/2020 2 2001 7 988,07 4 1056 4 263,47

Attachment



ANGI Monthly Metrics Available on IAC’s IR Site

NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) — IAC (NASDAQ: IAC) posted monthly metrics for December 2020, including metrics for ANGI Homeservices Inc. (NASDAQ: ANGI), on the investor relations section of IAC’s website at https://ir.iac.com/.

About ANGI Homeservices Inc.

ANGI Homeservices Inc. (NASDAQ: ANGI) turns home improvement jobs imagined into jobs well-done. People throughout North America and Europe rely on us to book quality home service pros across 500 different categories, from repairing and remodeling to cleaning and landscaping. Over 230,000 domestic service professionals actively seek consumer matches, complete jobs or advertise through ANGI Homeservices’ platforms and consumers turn to at least one of our brands to find a pro for more than 25 million projects each year. We’ve established category-transforming products through brands such as HomeAdvisor®, Angie’s List®, Handy and Fixd Repair – as well as international brands such as HomeStars, MyHammer, MyBuilder, Instapro, Travaux and Werkspot. Our marketplaces have enabled more than 150 million consumer-to-pro connections, meaningfully redefining how easily and effectively home pros are discovered and hired.  The Company is headquartered in Denver, Colorado. Learn more at www.angihomeservices.com. 

About IAC

IAC builds companies. We are guided by curiosity, a questioning of the status quo, and a desire to invent or acquire new products and brands. From the single seed that started as IAC over two decades ago have emerged 10 public companies and generations of exceptional leaders. We will always evolve, but our basic principles of financially-disciplined opportunism will never change. IAC today operates Vimeo, Dotdash and Care.com, among many others, and has majority ownership of ANGI Homeservices, which includes HomeAdvisor, Angie’s List and Handy. The Company is headquartered in New York City and has business operations and satellite offices worldwide.

Contacts:

IAC/ANGI Homeservices Investor Relations

Mark Schneider
(212) 314-7400

ANGI Homeservices Corporate Communications

Mallory Micetich
(303) 963-8352

IAC Corporate Communications

Valerie Combs
(212) 314-7361



Realty Income Announces Commencement of Common Stock Public Offering

PR Newswire

SAN DIEGO, Jan. 11, 2021 /PRNewswire/ — Realty Income Corporation (Realty Income, NYSE: O), The Monthly Dividend Company®, today announced that it has commenced an underwritten public offering of 10,500,000 shares of common stock. The company also plans to grant the underwriters a 30-day option to purchase up to 1,575,000 additional shares of common stock. The joint book-running managers for the offering are BofA Securities, Morgan Stanley, Wells Fargo Securities and Citigroup.

The company intends to use net proceeds from the offering, along with available cash and additional borrowings as necessary, to fund property acquisitions. As of January 8, 2021, the company had entered into agreements or letters of intent to acquire additional U.S. and U.K. properties with an aggregate estimated purchase price of approximately $676.8 million. Moreover, from January 1 through January 8, 2021, the company has acquired properties with an aggregate purchase price of approximately $130.7 million, which, when combined with the properties under agreement or letter of intent as of January 8, 2021, equals an aggregate estimated purchase price of approximately $807.5 million.

Any remaining net proceeds will be used for general corporate purposes and working capital, which may include additional acquisitions, developments or expansions and/or repayment of borrowings under the company’s $3.0 billion revolving credit facility and/or the company’s $1.0 billion commercial paper program. Acquisitions are subject to uncertainties and there can be no assurance that these planned property acquisitions will be completed at the prices or on the timetable or other terms currently contemplated, or at all, or that the company will enter into binding agreements to acquire properties as to which the company has entered into letters of intent.

A preliminary prospectus supplement and accompanying prospectus related to the public offering of these securities have been or will be filed with the Securities and Exchange Commission. Copies of the preliminary prospectus supplement and the accompanying prospectus, when available, may be obtained from BofA Securities, Attn: Prospectus Department, NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte, NC 28255-0001 or email: [email protected]; or Morgan Stanley, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014; or Wells Fargo Securities, Attention: Equity Syndicate Department, 500 West 33rd Street, New York, New York, 10001, at (800) 326-5897 or email: [email protected]; or Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, at (800) 831-9146 or email: [email protected].

These securities are offered pursuant to a Registration Statement that has become effective under the Securities Act. These securities are only offered by means of the preliminary prospectus supplement related to the offering and the related prospectus. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any offer or sale of these securities, in any state or other jurisdiction where, or to any person to whom, the offer, solicitation, or sale of these securities would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.


Forward-Looking Statements

Statements in this press release that are not strictly historical, including statements regarding planned acquisitions, are “forward-looking” statements. Forward-looking statements involve known and unknown risks, which may cause the company’s actual future results to differ materially from expected results. These risks include, among others, general economic conditions, domestic and foreign real estate conditions, tenant financial health, the availability of capital to finance planned growth, volatility and uncertainty in the credit markets and broader financial markets, changes in foreign currency exchange rates, property acquisitions and the timing of these acquisitions, charges for property impairments, the effects of the COVID-19 pandemic and the measures taken to limit its impact, the effects of pandemics or global outbreaks of contagious diseases or fear of such outbreaks, the company’s tenants’ ability to adequately manage its properties and fulfill their respective lease obligations to the company, and the outcome of any legal proceedings to which the company is a party, as described in the company’s filings with the Securities and Exchange Commission. Consequently, forward-looking statements should be regarded solely as reflections of the company’s current operating plans and estimates. Actual operating results and property acquisitions may differ materially from what is expressed or forecast in this press release. The company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date these statements were made.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/realty-income-announces-commencement-of-common-stock-public-offering-301205647.html

SOURCE Realty Income Corporation

GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020

CARLSBAD, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided preliminary operational and financial results for the year ended December 31, 2020.

Financial Highlights

  • Total revenue for 2020 is expected to be approximately $171 million, representing an increase of approximately 95% over 2019
    • ePlex® revenue for the full year 2020 is expected to be approximately $152 million, an increase of 155% over 2019
  • Total revenue for the fourth quarter of 2020 is expected to be approximately $50 million, representing an increase of 84% over the fourth quarter of 2019
    • ePlex revenue for the fourth quarter of 2020 is expected to be approximately $45 million, an increase of 138% over the fourth quarter of 2019
  • Gross margin is expected to be approximately 39% for the fourth quarter of 2020 and between 39% and 40% for the full year 2020

Operational Highlights

  • Placed 70 net new ePlex analyzers in the fourth quarter of 2020, finishing the year with an installed base of 792 ePlex analyzers placed worldwide
    • ePlex installed base grew 50% year over year
  • Fourth quarter annuity was approximately $220,000 per analyzer, compared to approximately $148,000 in the fourth quarter of 2019
  • Increased manufacturing capacity by more than 75% versus prior year with the completion of the first of two new production lines during the quarter

“Fourth quarter demand remained very strong, driven by our ePlex RP2 and blood culture ID panels that provide broad pathogen coverage and simplified workflow with hands on time of one minute or less,” said Scott Mendel, President and Chief Executive Officer. “During the quarter, we validated the first of our two new ePlex manufacturing lines that increases our production capacity to approximately 160,000 ePlex tests per month and we remain on track to validate the second line in the very near future.”

“With multi-year contracts that include committed volumes, GenMark has created an enduring and recurring revenue stream that provides visibility to driving continued top line growth in 2021. I’m proud of the entire GenMark organization, as we remained committed to our key priorities and delivered remarkable results throughout the entire year under extraordinary circumstances,” concluded Mendel.

These preliminary results are based on management’s initial analysis of operations for the quarter and year ended December 31, 2020 and are subject to further internal review and audit by the company’s external auditors. The company expects to issue full 2020 financial results and 2021 guidance in late February.

About GenMark Diagnostics

GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark’s proprietary eSensor® detection technology, GenMark’s eSensor XT-8® and ePlex® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. For more information, visit www.genmarkdx.com.

Forward Looking Statements

This press release includes forward-looking statements regarding events, trends and business prospects, which may affect our future operating results and financial position. Such statements, including, but not limited to, those regarding our preliminary, unaudited financial and operational performance, expected increases to our ePlex manufacturing capacity, and the timely FDA clearance and commercialization of additional ePlex panel menu, are all subject to risks and uncertainties that could cause our actual results and financial position to differ materially. Some of these risks and uncertainties include, but are not limited to, our ability to successfully validate additional ePlex manufacturing lines and commercialize our ePlex system and its related test menu in a timely manner, constraints or inefficiencies caused by unanticipated acceleration and deceleration of customer demand, our ability to successfully expand sales of our product offerings outside the United States, and third-party payor reimbursement to its customers, as well as other risks and uncertainties described under the “Risk Factors” in our public filings with the Securities and Exchange Commission. We assume no responsibility to update or revise any forward-looking statements to reflect events, trends or circumstances after the date they are made.

Investor Relations Contact

Leigh Salvo
(415) 937-5404
[email protected] 



Columbia Sportswear Appoints Tim Sheerin as Senior Vice President of U.S. Sales for the Columbia Brand

Columbia Sportswear Appoints Tim Sheerin as Senior Vice President of U.S. Sales for the Columbia Brand

PORTLAND, Ore.–(BUSINESS WIRE)–
Columbia Sportswear Company (Nasdaq: COLM), a leading innovator in active outdoor apparel, footwear, accessories and equipment, today announced the appointment of Tim Sheerin as Senior Vice President of U.S. Sales for the Columbia brand.

In his new role, Sheerin will report to Franco Fogliato, Executive Vice President, Global Omni-Channel.

“Tim brings a wealth of experience in commercial leadership,” said Franco Fogliato. “His background in strategy, coupled with his years catalyzing high-performance teams, will help us accelerate growth for the Columbia brand in 2021 and beyond.”

Prior in joining Columbia, Sheerin spent twenty years in various senior-level sales and strategy roles at Nike. In his most recent role as Vice President of North America Sales, he led Nike’s wholesale business across Nike and Jordan brands, supporting all product lines and categories for North America.

“In his new role, Tim is poised to consolidate the strong leading position of the Columbia brand with his knowledge of the U.S. market and extensive network of relationships with customers,” said Fogliato. “We could not be happier to kick off the year with a leader of his caliber.”

About Columbia:

Columbia, the flagship brand of Portland, Oregon-based Columbia Sportswear Company, has been creating innovative apparel, footwear, accessories and equipment for outdoor enthusiasts since 1938. Columbia has become a leading global brand by channeling the company’s passion for the outdoors and innovative spirit into technologies and performance products that keep people warm, dry, cool and protected year-round. To learn more, please visit the company’s website at www.columbia.com.

Forward-Looking Statements:

This document may contain forward-looking statements within the meaning of the federal securities laws. Forward-looking statements often use words such as “will,” “anticipate,” “estimate,” “expect,” “should,” “may” and other words and terms of similar meaning or reference future dates. The Company’s expectations, beliefs and projections are expressed in good faith and are believed to have a reasonable basis; however, each forward-looking statement involves a number of risks and uncertainties, including those set forth in this document, those described in the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q under the heading “Risk Factors,” and those that have been or may be described in other reports filed by the Company, including reports on Form 8-K. The Company cautions that forward-looking statements are inherently less reliable than historical information. The Company does not undertake any duty to update any of the forward-looking statements after the date of this document to conform them to actual results or to reflect changes in events, circumstances or its expectations. New factors emerge from time to time and it is not possible for the Company to predict or assess the effects of all such factors or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement.

Mary Ellen Glynn

Director of Corporate Communications

Columbia Sportswear Company

[email protected]

KEYWORDS: Oregon United States North America

INDUSTRY KEYWORDS: Retail Sports Other Retail Manufacturing Outdoors Specialty Textiles

MEDIA:

Logo
Logo